Micron Technology, Inc. (MU) Stock Price Today
Aura AI Summary
Key Stats
- $1.13TMarket Cap
- -Volume
- TechnologySector
- $1.21K52W High
- $135.2452W Low
- -Typical Hold Time
- $1.11TEnterprise Value
- 0.05%Div Yield
- -Trading Activity
Track Micron Technology, Inc. (MU) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Micron Technology, Inc. has traded between a low of $135.24 and a high of $1,213.56, highlighting its annual price range. Buy and sell Micron Technology, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Micron Technology, Inc.
Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Most Recent News
Novartis shares plunge 12.5% after two Phase 3 drug trials fail primary goals
Novartis shares dropped over 12.5% after its Phase 3 HARBOR trial for del-desiran and Phase 3 HORIZON trial for pelacarsen both failed to meet primary endpoints. These failures mean the drugs did not show significant benefits over placebo for their t...

Levi & Korsinsky probes lululemon over tariff refund disclosures after earnings and guidance cuts.
Levi & Korsinsky is investigating lululemon athletica for potentially misleading disclosures about a $134.5 million federal tariff refund included in its recent quarterly earnings. The refund boosted earnings per share by $0.86 and operating margins,...

Structure Therapeutics shows strong obesity drug results, remains a strong buy with $1.3B cash runway.
Structure Therapeutics reported promising 72-week data for its oral obesity drug aleniglipron, showing 16.2% weight loss with low adverse event discontinuations and no liver injury. The company also advanced ACCG-2671, an oral amylin agonist with hum...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.